Microbix Biosystems Inc (MBXBF)

[yielddude]

Microbix MBX.TO MBXBF more paraphrasing from interview at 5:45 ....

We did 10.5M last year, we'll do over $18M this year, and we're currently budgeting for 2022, which will be another record year and substantially up from fiscal 2021.

which leads into his undervaluation comment.

So they have 3 record quarters in a row, expect a record year in 2022, and letting investors know that if they continue to be undervalued, it's likely a life sciences company will recognize that and take them out (buyout). That's pretty much what I have been seeing and thinking. Time will tell.